Detalhe da pesquisa
1.
FPR3 reprograms glycolytic metabolism and stemness in gastric cancer via calcium-NFATc1 pathway.
Cancer Lett
; 593: 216841, 2024 Apr 16.
Artigo
Inglês
| MEDLINE | ID: mdl-38614385
2.
Lactate/GPR81 recruits regulatory T cells by modulating CX3CL1 to promote immune resistance in a highly glycolytic gastric cancer.
Oncoimmunology
; 13(1): 2320951, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38419759
3.
Gut microbiota modulate CD8+ T cell immunity in gastric cancer through Butyrate/GPR109A/HOPX.
Gut Microbes
; 16(1): 2307542, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38319728